The Executive Committee consists of experienced professionals with extensive experience in the pharmaceutical industry. They are responsible for the strategic decisions related to Tillotts. They set the company objectives based on input from the Management Committee (MC), in line with our vision and mission. Learn more about each member here.
Thomas A. Tóth von Kiskér,
Chief Executive Officer
Thomas A. Tóth von Kiskér has been with Tillotts for more than 20 years starting in Sales & Marketing.
In 2001 he was promoted to Director of Business Development & Licensing and in 2005 to Director of Corporate Development.
Since January 2008, he has been the CEO of Tillotts.
Chief Operations Officer
Mattias Norrman joined Tillotts in late 2008 and set up the affiliate business in a number of European countries, a continuing process to strengthen Tillotts’ presence in the market.
He has been in the pharmaceutical industry for 28 years in various senior management positions in companies, such as J&J, Bayer and Schering.
The MC consists of six experienced individuals responsible for the operational activities at Tillotts. They ensure the effective management of Tillotts together with various steering committees as well as provide input and recommendations to the Executive Committee. Moreover, they monitor the activities of the organisation to ensure they are in line with our company objectives and values. Learn more about each member below.
Head of Finance
Marcel Portmann joined Tillotts in October 2015. Prior to joining Tillotts, he worked as Head Group Reporting and Consolidation for a stock exchange listed Swiss energy company and before that, in different Swiss small and medium-sized enterprises in various finance roles.
Head of HR
Gabriella Schraner joined Tillotts in 2013. In February 2016, she was promoted to Head of HR. She is a Human Resources expert by training with specialization in International HR with more than 10 years of experience. Prior to Tillotts, she mainly worked in the biotechnology industry.
Head of Technical Operations
Harald Haubitz joined Tillotts in January 2018. He is a pharmacist by training with over 25 years of experience in the pharmaceutical industry. Previously he held different management positions at Roche and was the COO of Acino for several years before he ran his own consultancy business.
Head of Commercial Operations
Adrian Hill joined Tillotts in January 2019. He has more than 25 years experience in commercial activities including experience in global marketing from several companies including Sanofi, GSK and most recently Kyowa Kirin.
Barbara Lange joined Tillotts in November 2019. She is a lawyer by training with almost 20 years of work experience as an in-house legal counsel having spent almost 15 years with Novartis/Alcon and recently with Bayer Consumer Care.
Head of Scientific Affairs
Johannes Spleiss joined Tillotts in November 1998. He took on positions of increasing responsibility and is now leading R&D, Medical Affairs, Drug Safety and Regulatory Affairs. A chemist by training, he has 30 years of experience in the pharmaceutical industry.
Head of Business Development & Licensing International
Ragip Ziyal joined Tillotts in April 2014. He has 25 years of experience in global Business, Corporate Development and Licensing functions working for Merz Pharmaceuticals, Fujisawa (now Astellas), Altana/Nycomed/Takeda. He is a licensed pharmacist by training, has a PhD degree in pharmacology in Germany and holds an MBA from Warwick Business School, UK.
Chair of Management Committee
See info under Executive Committee